Full in-frame exon 3 skipping of BRCA2 confers high risk of breast and/or ovarian cancer.
about
Full in-frame exon 3 skipping of BRCA2 confers high risk of breast and/or ovarian cancer.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Full in-frame exon 3 skipping of BRCA2 confers high risk of breast and/or ovarian cancer.
@en
Full in-frame exon 3 skipping of BRCA2 confers high risk of breast and/or ovarian cancer.
@nl
type
label
Full in-frame exon 3 skipping of BRCA2 confers high risk of breast and/or ovarian cancer.
@en
Full in-frame exon 3 skipping of BRCA2 confers high risk of breast and/or ovarian cancer.
@nl
altLabel
Full in-frame exon 3 skipping of
@en
prefLabel
Full in-frame exon 3 skipping of BRCA2 confers high risk of breast and/or ovarian cancer.
@en
Full in-frame exon 3 skipping of BRCA2 confers high risk of breast and/or ovarian cancer.
@nl
P2093
P2860
P50
P356
P1433
P1476
Full in-frame exon 3 skipping of BRCA2 confers high risk of breast and/or ovarian cancer.
@en
P2093
Alexandra Martins
Ambre Petitalot
Ana Peixoto
Aura Carreira
Capucine Delnatte
Claude Houdayer
Cédrick Lefol
Danièle Muller
P2860
P304
17334-17348
P356
10.18632/ONCOTARGET.24671
P407
P577
2018-04-03T00:00:00Z